The team mapped regulatory DNA regions called enhancers near CHD8 and SCN2A, then used them as targets for CRISPR-based gene activation. The approach was tested in excitatory neurons and cerebral forebrain organoids made from human pluripotent stem cells, which can develop features of the human brain in the laboratory.

In mutant neurons and organoids, enhancer targeting produced a sustained increase in the affected gene’s activity. The researchers report that this restored gene-expression levels and corrected mutation-associated changes in gene expression and physiology.